150 related articles for article (PubMed ID: 8623385)
1. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF.
Byrne G; McCurry K; Martin M; Platt J; Logan J
Transplant Proc; 1996 Apr; 28(2):759. PubMed ID: 8623385
[No Abstract] [Full Text] [Related]
2. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.
McCurry KR; Diamond LE; Kooyman DL; Byrne GW; Martin MJ; Logan JS; Platt JL
Transplant Proc; 1996 Apr; 28(2):758. PubMed ID: 8623384
[No Abstract] [Full Text] [Related]
3. How can human DAF and HRF20 prevent HAR in transgenic mice?
Koike C; Isobe K; Nakashima I; Okada H; Hayashi S; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):599-600. PubMed ID: 8623294
[No Abstract] [Full Text] [Related]
4. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses.
Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF
Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558
[TBL] [Abstract][Full Text] [Related]
5. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of human CD59 and human CD55 in transgenic mice.
Somerville C; van Denderen B; Adam B; Aminian A; Allison J; Pearse M; d'Apice A
Transplant Proc; 1995 Dec; 27(6):3565-6. PubMed ID: 8540103
[No Abstract] [Full Text] [Related]
9. Effects of combined expression of human complement regulatory proteins and H-transferase on the inhibition of complement-mediated cytolysis in porcine embryonic fibroblasts.
Lee JH; Lee HJ; Nahm KM; Jeon HY; Hwang WS; Paik NW; Rho HM
Transplant Proc; 2006 Jun; 38(5):1618-21. PubMed ID: 16797369
[TBL] [Abstract][Full Text] [Related]
10. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
[No Abstract] [Full Text] [Related]
11. High-level tissue specific expression of human CD59, MCP, and DAF proteins from genomic clones in transgenic mice.
Oldham ER; Velardo MA; Platt JL; Logan JS; Diamond L
Transplant Proc; 1996 Apr; 28(2):693. PubMed ID: 8623349
[No Abstract] [Full Text] [Related]
12. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo studies to prevent hyperacute rejection.
Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
[No Abstract] [Full Text] [Related]
14. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
15. Complement regulatory molecules: application to therapy and transplantation.
Morgan BP
Immunol Today; 1995 Jun; 16(6):257-9. PubMed ID: 7544975
[No Abstract] [Full Text] [Related]
16. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
[TBL] [Abstract][Full Text] [Related]
17. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
18. Transgenic human DAF-expressing porcine livers: their function during hemoperfusion with human blood.
Pöhlein C; Pascher A; Storck M; Young VK; König W; Abendroth D; Wick M; Thiery J; White DJ; Hammer C
Transplant Proc; 1996 Apr; 28(2):770-1. PubMed ID: 8623394
[No Abstract] [Full Text] [Related]
19. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
20. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
[No Abstract] [Full Text] [Related]
[Next] [New Search]
